Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/EBIT

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 37.39-0.150.25-0.25-0.17

What is the latest EV/EBIT ratio of MANKIND PHARMA ?

The latest EV/EBIT ratio of MANKIND PHARMA is 37.39 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202437.39
Mar2023-0.15
Mar20220.25
Mar2021-0.25
Mar2020-0.17

How is EV/EBIT of MANKIND PHARMA Trending?

Years EV/EBIT % Change
Mar2024 37.39
Positive
Mar2023 -0.15
Negative
Mar2022 0.25
Positive
Mar2021 -0.25
Negative
Mar2020 -0.17 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/EBIT ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,144.2 Cr 0.7% -6.7% 10.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,824.0 Cr 0.5% -0.5% 14.6% Stock Analytics
DIVIS LABORATORIES ₹178,355.0 Cr 1.3% 10.7% 49.3% Stock Analytics
CIPLA ₹122,929.0 Cr 2.2% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr 4.7% 11.9% 14.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,502.0 Cr 2% -0.8% 15.7% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.7%

-6.7%

10.3%

SENSEX

1.9%

0.1%

10.9%


You may also like the below Video Courses